![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Once Daily Sofosbuvir/Ledipasvir Fixed-Dose Combination With Ribavirin in Patients With Inherited Bleeding Disorders and HCV Infection
|
|
|
Reported by Jules Levin
Asian Pacific Association for the Study of the Liver (APASL), March 12-15, 2014, Brisbane, Australia
Catherine A. Stedman,1 Robert H. Hyland,2 Xiao Ding,2 Phil S. Pang,2 William T. Symonds,2 John G. McHutchison,2 Edward J. Gane3
1Christchurch Clinical Studies Trust, Christchurch, New Zealand; 2Gilead Sciences, Inc, Foster City, CA, USA; 3Auckland Clinical Studies, Auckland, New Zealand
![APASL1.gif](../images/031714/031714-9/APASL1.gif)
![APASL2.gif](../images/031714/031714-9/APASL2.gif)
![APASL3.gif](../images/031714/031714-9/APASL3.gif)
![APASL4.gif](../images/031714/031714-9/APASL4.gif)
![APASL5.gif](../images/031714/031714-9/APASL5.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|